ArticleInvestigational new drugs2017

Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors.

Luis Paz-Ares et al.PubMed ↗Publisher ↗

No numbers read from the abstract.